38 related articles for article (PubMed ID: 16507485)
1. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID).
Ferguson TA; Kaplan HJ
Reg Immunol; 1988; 1(1):62-8. PubMed ID: 2978943
[TBL] [Abstract][Full Text] [Related]
2. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
Niederkorn JY; Mayhew E
Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
[TBL] [Abstract][Full Text] [Related]
3. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
4. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
5. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
Ferguson TA; Herndon JM
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
[TBL] [Abstract][Full Text] [Related]
6. Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain mice.
Herndon J; Gibler TS; Ferguson TA; Van Gelder RN
Ocul Immunol Inflamm; 2006 Feb; 14(1):7-12. PubMed ID: 16507485
[TBL] [Abstract][Full Text] [Related]
7. Anterior chamber-associated immune deviation.
Biros D
Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):309-21, vi-vii. PubMed ID: 18299009
[TBL] [Abstract][Full Text] [Related]
8. A privileged view of NKT cells and peripheral tolerance through the eye.
Stein-Streilein J
Ocul Immunol Inflamm; 2005; 13(2-3):111-7. PubMed ID: 16019670
[TBL] [Abstract][Full Text] [Related]
9. Immune regulation and the eye: a dangerous compromise.
Streilein JW
FASEB J; 1987 Sep; 1(3):199-208. PubMed ID: 2957263
[TBL] [Abstract][Full Text] [Related]
10. Invariant NKT cells and tolerance.
Nowak M; Stein-Streilein J
Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
[TBL] [Abstract][Full Text] [Related]
11. Anterior chamber associated immune deviation: the privilege of immunity in the eye.
Streilein JW
Surv Ophthalmol; 1990; 35(1):67-73. PubMed ID: 2204129
[TBL] [Abstract][Full Text] [Related]
12. Potential use of in vitro anterior chamber-associated immune deviation (ACAID) for the immunotherapeutic prevention of autoimmune disease and graft rejection.
Koevary SB
Ther Immunol; 1995 Aug; 2(4):203-10. PubMed ID: 9358612
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]